Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide and Thalidomide in Leiomyosarcoma
NCT00033709Phase 2Unknown
- Sponsor
- Herbert Irving Comprehensive Cancer Center
- Start
- Mar 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide, thalidomide in leiomyosarcoma (LMS), sponsored by Herbert Irving Comprehensive Cancer Center. Status: unknown.
02
Drugs
temozolomidethalidomide
03
Conditions
leiomyosarcoma (LMS)
Beyond the preview
Go deeper on NCT00033709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033709.